Piracetam Ameliorated Oxygen and Glucose Deprivation-Induced Injury in Rat Cortical Neurons Via Inhibition of Oxidative Stress, Excitatory Amino Acids Release and P53/Bax
详细信息 查看全文
- 作者：Zhi He (1)
Min Hu (1)
Yun-hong Zha (2)
Zi-cheng Li (1)
Bo Zhao (1)
Ling-ling Yu (1)
Min Yu (2)
Ying Qian (3) - 关键词：Piracetam ; Oxygen and glucose deprivation ; Glutamate ; P53 ; Bax
- 刊名：Cellular and Molecular Neurobiology
- 出版年：2014
- 出版时间：May 2014
- 年：2014
- 卷：34
- 期：4
- 页码：539-547
- 全文大小：657 KB
- 参考文献：1. Adibhatla RM, Hatcher JF (2006) Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic Biol Med 40:376-87 CrossRef
2. Armstrong D, Browne R (1994) The analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory. Adv Exp Med Biol 366:43-8 CrossRef
3. Berger C, Stauder A, Xia F, Sommer C, Schwa S (2008) Neuroprotection and glutamate attenuation by acetylsalicylic acid in temporary but not in permanent cerebral ischemia. Exp Neurol 210:543-48 CrossRef
4. Brad RSB, David CR, Christopher GS (2009) Apoptotic mechanisms after cerebral ischemia. Stroke 40:331-39 CrossRef
5. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-54 CrossRef
6. Chen XM, Chen HS, Xu MJ, Shen JG (2013) Targeting reactive nitrogen species: a promising therapeutic strategy for cerebral ischemia-reperfusion injury. Acta Pharmacol Sin 34:67-7 CrossRef
7. Chong ZZ, Li F, Maiese K (2005) Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease. Prog Neurobiol 75:207-46 CrossRef
8. Dohmen C, Kumura E, Rosner G, Heiss WD, Graf R (2005) Extracellular correlates of glutamate toxicity in short-term cerebral ischemia and reperfusion: a direct in vivo comparison between white and gray matter. Brain Res 1037:43-1 CrossRef
9. He Z, Liao Y, Zheng M, Zeng F, Guo L (2008) Piracetam improves cognitive deficits caused by chronic cerebral hypoperfusion in rats. Cell Mol Neurobiol 28:613-27 CrossRef
10. He Z, Lu Q, Xu X, Huang L, Chen J, Guo L (2009) DDPH ameliorated oxygen and glucose deprivation-induced injury in rat hippocampal neurons via interrupting Ca2+ overload and glutamate release. Eur J Pharmacol 603:50-5 CrossRef
11. Hong LZ, Zhao XY, Zhang HL (2010) P53-mediated neuronal cell death in ischemic brain injury. Neurosci Bull 26:232-40 CrossRef
12. Huang L, Li Q, Li H, He Z, Cheng Z, Chen J, Guo L (2009) Inhibition of intracellular Ca2+ release by a Rho-kinase inhibitor for the treatment of ischemic damage in primary cultured rat hippocampal neurons. Eur J Pharmacol 602:238-44 CrossRef
13. Hwang IK, Yoo KY, Kim DW, Kang TC, Choi SY, Kwon YG, Han BH, Kim JS, Won MH (2006) Na+/Ca2+ exchanger 1 alters in pyramidal cells and expresses in astrocytes of the gerbil hippocampal CA1 region after ischemia. Brain Res 1086:181-90 CrossRef
14. Jeon D, Chu K, Jung KH, Kim M, Yoon BW, Lee CJ, Oh U, Shin HS (2008) Na+/Ca2+ exchanger 2 is neuroprotective by exporting Ca2+ during a transient focal cerebral ischemia in the mouse. Cell Calcium 43:482-91 CrossRef
15. Kalkan E, Keskin F, Kaya B, Esen H, Tosun M, Kalkan SS, Erdi F, Unlü A, Avunduk MC, Cicek O (2011) Effects of iloprost and piracetam in spinal cord ischemia-reperfusion injury in the rabbit. Spinal Cord 49(1):81-6 CrossRef
16. Kasˇparova S, Brezova V, Valko M, Horecky J, Mlyna′rik V, Liptaj T, Vancˇova O, Ulicˇna O, Dobrota D (2005) Study of the oxidative stress in a rat model of chronic brain hypoperfusion. Neurochem Int 46:601-11 CrossRef
17. Katsumata T, Muramatsu H, Nakamura H, Nishiyama Y, Aoki Y, Katayama Y (2003) Neuroprotective effect of NS-7, a novel Na and Ca channel blocker, in a focal ischemic model in the rat. Brain Res 969:168-74 CrossRef
18. Koh TY, Choi DW (1987) Quantitative determination of glutamate mediated-cortical neuronal injury in cell culture by lactate dehydrogenaser efflux assay. J Neurosci Meth 20:83-0 CrossRef
19. Li YX, Ding SJ, Xiao L, Guo W, Zhan Q (2008) Desferoxamine preconditioning protects against cerebral ischemia in rats by inducing expressions of hypoxia inducible factor 1 alpha and erythropoietin. Neurosci Bull 24:89-5 CrossRef
20. Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer’s disease. Free Radic Biol Med 23:134-47 CrossRef
21. Meenakshisundaram T, Shyam SS (2004) Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci 74:969-85 CrossRef
22. Mori T, Tateishi N, Kagamiishi Y, Shimoda T, Satoh S, Ono S, Katsube N, Asano T (2004) Attenuation of a delayed increase in the extracellular glutamate level in the peri-infarct area following focal cerebral ischemia by a novel agent ONO-2506. Neurochem Int 45:381-87 CrossRef
23. Niizuma K, Yoshioka H, Chen H, Kim GS, Jung JE, Katsu M, Okami N, Chan PH (2010) Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia. Biochim Biophys Acta 1802:92-9 CrossRef
24. Nijboer CH, Heijnen CJ, van der Kooij MA, Zijlstra J, van Velthoven CT, Culmsee C, van Bel F, Hagberg H, Kavelaars A (2011) Targeting the?p53?pathway to protect the neonatal ischemic?brain. Ann Neurol 70(2):255-64. doi:10.1002/ana.22413 CrossRef
25. Nishizawa Y (2001) Glutamate release and neuronal damage in ischemia. Life Sci 69:369-81 CrossRef
26. Raz L, Zhang QG, Han D, Dong Y, De Sevilla L, Brann DW (2011) Acetylation of the pro-apoptotic factor,?p53?in the hippocampus following cerebral?ischemia and modulation by estrogen. PLoS ONE 6(10):e27039. doi:10.1371/journal.pone.0027039 CrossRef
27. Rydh-Rinder M, Kerekes N, Svensson M, Ho¨kfelt T (2001) Glutamate release from adult primary sensory neurons in culture is modulated by growth factors. Regul Pept 102:69-9 CrossRef
28. Samuel G, Simone P, Iuri MO, Cristiano T, Renat MR, Jo?o APH, Jaderson CD (2011) NAP prevents acute cerebral oxidative stress and protects against long-term brain injury and cognitive impairment in a model of neonatal hypoxia–ischemia. Neurobiol Dis 44:152-59
29. Shen Y, Zhang S, Fu L, Hu W, Chen Z (2008) Carnosine attenuates mast cell degranulation and histamine release induced by oxygen-glucose deprivation. Cell Biochem Funct 26:334-38 CrossRef
30. Sperlagh B, Zailla G, Baranyi M, Illes P, Vizi ES (2007) Purinergic modulation of glutamate release under ischemic-like conditions in the hippocampus. Neuroscience 149:99-11 CrossRef
31. Tauskela JS, Morley P (2004) On the role of Ca2+ in cerebral ischemic preconditioning. Cell Calcium 36:313-22 CrossRef
32. Tiurenkov IN, Bagmetov MN, Epishina VV (2007) Comparative evaluation of the neuroprotective activity of phenotropil and piracetam in laboratory animals with experimental cerebral ischemia. Eksp Klin Farmakol 70:24-9
33. Vannucci RC, Brucklacher RM, Vannucci SJ (2001) Intracellular calcium accumulation during the evolution of hypoxic–ischemic brain damage in the immature rat. Brain Res Dev Brain Res 126:117-20 CrossRef
34. White BC, Sullivan JM, DeGracia DJ, O’Neil BJ, Neumar RW, Grossman LI, Rafols JA, Krause JS (2000) Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neurol Sci 179:1-3 CrossRef
35. Wu JB, Song NN, Wei XB, Guan HS, Zhang XM (2008) Protective effects of paeonol on cultured rat hippocampal neurons against oxygen-glucose deprivation-induced injury. J Neurol Sci 264:50-5 CrossRef
36. Xu W, Zha RP, Wang WY, Wang YP (2007) Effects of scutellarin on PKC gamma in PC12 cell injury induced by oxygen and glucose deprivation. Acta Pharmacol Sin 28:1573-579 CrossRef
37. Yanpallewara SU, Raib S, Kumarb M, Acharyaa SB (2004) Evaluation of antioxidant and neuroprotective effect of / Ocimum sanctum on transient cerebral ischemia and long-term cerebral hypoperfusion. Pharmacol Biochem Behav 79:155-64 CrossRef
38. Yokota M, Saido TC, Kamitani H, Tabuchi S, Satokata I, Watanabe T (2003) Calpain induces proteolysis of neuronal cytoskeleton in ischemic gerbil forebrain. Brain Res 984:122-32 CrossRef
39. Zhang Y, Fan X, Li X, Peng L, Wang G, Ke K, Jiang Z (2008) Ginsenoside Rg1 protects neurons from hypoxic–ischemic injury possibly by inhibiting Ca2+ influx through NMDA receptors and L-type voltage-dependent Ca2+ channels. Eur J Pharmacol 586:90-9 CrossRef
40. Zhao YM, Sun LN, Zhou HY, Wang XL (2006) Voltage-dependent potassium channels are involved in glutamate-induced apoptosis of rat hippocampal neurons. Neurosci Lett 398:22-7 CrossRef - 作者单位：Zhi He (1)
Min Hu (1)
Yun-hong Zha (2)
Zi-cheng Li (1)
Bo Zhao (1)
Ling-ling Yu (1)
Min Yu (2)
Ying Qian (3)
1. Medical School of China Three Gorges University, Yichang, China
2. The First Renmin Hospital of Yichang City, Yichang, China
3. Department of Obstetrics and Gynecology, East Hospital, Tongji University, Shanghai, China - ISSN：1573-6830
文摘
Our previous work has demonstrated that piracetam inhibited the decrease in amino acid content induced by chronic hypoperfusion, ameliorated the dysfunction of learning and memory in a hypoperfusion rat model, down-regulated P53, and BAX protein, facilitated the synaptic plasticity, and may be helpful in the treatment of vascular dementia. To explore the precise mechanism, the present study further evaluated effects of piracetam on Oxygen and glucose deprivation (OGD)-induced neuronal damage in rat primary cortical cells. The addition of piracetam to the cultured cells 12?h before OGD for 4?h significantly reduced neuronal damage as determined by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay and lactate dehydrogenase release experiments. Piracetam also lowered the levels of malondialdehyde, nitrogen monoxidum, and xanthine oxidase which was increased in the OGD cells, and enhanced the activities of superoxide dismutase and glutathione peroxidase, which were decreased in the OGD cells. We also demonstrated that piracetam could decrease glutamate and aspartate release when cortical cells were subjected to OGD. Furthermore, Western blot study demonstrated that piracetam attenuated the increased expression of P53 and BAX protein in OGD cells. These observations demonstrated that piracetam reduced OGD-induced neuronal damage by inhibiting the oxidative stress and decreasing excitatory amino acids release and lowering P53/Bax protein expression in OGD cells.